Learning Objectives:

  1. Review the development of clinical models of breast cancer recurrence
  2. Discuss available multigene assays that predict recurrence
  3. Integrate clinical and genomic data to inform the use of adjuvant chemotherapy



  1. Review incidence of prognostic communication in multiple settings
  2. Examine how prognostic communication impacts patients’ perceptions, treatment choices and advance care planning
  3. Discuss strategies to increase prognostic communication
Session date: 
08/19/2019 - 12:00pm to 1:00pm CDT
5841 South Maryland Avenue
MC2115 HemOnc Conference Room E-215
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Frederick H. Howard, MD and Joseph J. Heng, MD